Finance

Lists
538965:BOM
Concord Drugs Ltd
₹71,80
+1,83%
(+1,29) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 538965...
Open
₹70,10
High
₹72,40
Low
₹69,50
Mkt. cap
945,97 m
Avg. vol.
4,69 k
Volume
782,00
P/E ratio
32,04
52-wk high
₹92,52
52-wk low
₹61,00
EPS
₹2,24
Shares outstanding
7,86 m
No. of employees
250
Open
₹70,10
High
₹72,40
Low
₹69,50
Mkt. cap
945,97 m
Avg. vol.
4,69 k
Volume
782,00
P/E ratio
32,04
52-wk high
₹92,52
52-wk low
₹61,00
EPS
₹2,24
Shares outstanding
7,86 m
No. of employees
250
News stories
From web sources and news partners
About Concord Drugs Ltd
CEO-
Employees250
Founded1995
Headquarters-
SectorPharmaceutical industry
Websiteconcorddrugs.in
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
102,76 m
169,66 m
378,88 m
209,39 m
Cost of goods sold
77,18 m
143,91 m
344,01 m
169,14 m
Cost of revenue
77,18 m
143,91 m
344,01 m
169,14 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,95 m
12,37 m
17,53 m
12,56 m
Operating expense
18,01 m
19,60 m
23,55 m
20,92 m
Total operating expenses
95,19 m
163,52 m
367,56 m
190,06 m
Operating income
7,57 m
6,15 m
11,32 m
19,33 m
Other non operating income
26,00 k
211,00 k
-1,14 m
82,00 k
EBT including unusual items
2,71 m
2,96 m
7,48 m
15,45 m
EBT excluding unusual items
2,71 m
2,96 m
7,48 m
15,45 m
Income tax expense
789,00 k
792,00 k
2,20 m
4,31 m
Effective tax rate
29,08%
26,75%
29,36%
27,89%
Other operating expenses
3,67 m
4,16 m
2,50 m
4,87 m
Net income
1,92 m
2,17 m
5,28 m
11,14 m
Net profit margin
1,87%
1,28%
1,39%
5,32%
Earnings per share
-
-
-
-
Interest and investment income
-
-
334,00 k
-
Interest expense
-4,88 m
-3,40 m
-3,04 m
-3,96 m
Net interest expenses
-4,88 m
-3,40 m
-2,71 m
-3,96 m
Depreciation and amortization charges
3,39 m
3,07 m
3,53 m
3,49 m
EBITDA
11,10 m
9,72 m
14,74 m
22,74 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme